US biotech PureTech Health is to develop therapies that are based on a new theory that neurological diseases such as Alzheimer’s are linked to drainage issues in the brain.
AbbVie needs new drugs as its mega-blockbuster Humira won’t bring in billions forever – and after the embarrassing withdrawal of an MS drug earlier this year it has managed to get a substan
Biogen and Eisai said their latest clinical study confirmed the amyloid hypothesis and might lead to the first drug successfully treating Alzheimer’s disease, instantly bumping their share
